Hybrid single-photon emission computed tomography–computed tomography (SPECT-CT) imaging results in chronic low back pain patients as compared to an asymptomatic control group

ISRCTN ISRCTN52513588
DOI https://doi.org/10.1186/ISRCTN52513588
Protocol serial number 2013-06/02
Sponsor AZ Nikolaas
Funders Neuro-surgery.org (Belgium), The investigation (SPECT-CT) is part of the normal diagnostic process for the patients, thus the costs involved are carried by the patients’ individual health insurance.
Submission date
26/12/2013
Registration date
17/02/2014
Last edited
16/01/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
For patients with low chronic low back pain that is not cured by conservative treatment, more invasive treatments can be considered. Those treatments may consist in injection, application of high frequency current or surgery. Success is dependent on how precisely the painful structure is identified. The new molecular imaging modality SPECT-CT detects increased bone metabolism during the degeneration process. It might be helpful in identifying the chronic low back pain phenotype. We want to evaluate the sensitivity of this molecular imaging modality in a group of patients suffering from chronic low back pain, as compared to a control group with no chronic back pain.

Who can participate?
Patients older than 18 years with chronic (> 3 months) low back pain without a specific pain phenotype on MRI, CT and classical X-Ray are referred for SPECT-CT imaging. In the control group, the patients were referred for SPECT-CT for other reasons than chronic low back pain.

What does the study involve?
Patients are asked if they consent to the analysis of their data. All patients undergo a SPECT-CT as planned within the diagnostic process for their condition.

What are the possible benefits and risks of participating?
This study is about data analysis only and there are no benefits or additional risks in participating. On rare occasions patients may be allergic to the product that is injected for imaging.

Where is the study run from?
AZ Nikolaas Hospital, Sint Niklaas, Belgium.

When is the study starting and how long is it expected to run for?
August 2013 to January 2014.

Who is funding the study
The SPECT-CT is part of the normal diagnostic process and is paid for by the standard procedure (health insurance). Costs for data recording and analysis are covered by the investigator.

Who is the main contact?
Dr Erik Van de Kelft, Director of the Neurosurgery Department, erik.vandekelft@aznikolaas.be
Dr Koen Melis, Director of the Neuroradiology Department, koen.melis@aznikolaas.be

Contact information

Dr Erik Van de Kelft
Scientific

Moerlandstraat, 1
Sint Niklaas
9100
Belgium

Phone +32 (0)3 760 21 72
Email erik.vandekelft@aznikolaas.be

Study information

Primary study designObservational
Study designProspective comparative study
Secondary study designOther
Study type Participant information sheet
Scientific titleEvaluation of the prevalence of increased Phosphorus uptake at lumbar level during SPECT-CT in a group of patients with low back pain as compared to an asymptomatic a control group
Study objectivesSPECT-CT shows “hotspots” at places with an increased phosphate metabolism due to mechanical stress. This is indicative for increased bone metabolism as result of the degeneration process. We hypothesize that the prevalence of hotspots observed during SPECT-CT will be higher in the group of patients with chronic low back pain as compared to an asymptomatic control group.
Ethics approval(s)Medical Ethics Committee of AZ Nikolaas, Sint Niklaas Belgium, Ref: EC 13022
Health condition(s) or problem(s) studiedSensitivity of SPECT-CT in the identification of the pain phenotype when analyzing chronic low back pain
InterventionPatients with chronic low back pain (more than 3 months) are referred for SPECT-CT imaging. In the control group, the patients were referred for SPECT-CT for other reasons than chronic low back pain.

All patients undergo a SPECT-CT as planned within the diagnostic process for their condition. The imaging data will be analyzed.
Intervention typeProcedure/Surgery
Primary outcome measure(s)

Number of patients with “hotspots” on SPECT-CT in the group with chronic low back pain, compared to the number of patients with “hotspots” on SPECT-CT in the group without chronic low back pain.

Key secondary outcome measure(s)

Analysis of the structures that show activity in both groups. The SPECT-CT images are read by the neuroradiologist immediately after the investigation. As the value of SPECT-CT as diagnostic tool for spinal pain is measured the interpretation of the images is done only once.

Completion date30/01/2014

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration200
Total final enrolment200
Key inclusion criteria1. Patients older than 18 years
2. Referred to the department of medical imaging for SPECT-CT
3. Having signed the informed consent
Key exclusion criteria1. Recent vertebral fractures
2. History of lumbar spine surgery
3. Diagnosed malignancy
4. Pregnancy
5. Contraindication for injection 99mTc hydroxymethane diphosphonate (99MTc-HDP)
Date of first enrolment08/08/2013
Date of final enrolment30/01/2014

Locations

Countries of recruitment

  • Belgium

Study participating centre

Moerlandstraat, 1
Sint Niklaas
9100
Belgium

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2017 16/01/2020 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

16/01/2020: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.